A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

8.9K views

⸱

DOI:

10.3791/54997

⸱

April 28th, 2017

 ,  ,  ,  ,  , 

In This Article

Summary

Infections caused by multidrug-resistant (MDR) bacterial strains have emerged as a serious threat to public health, necessitating the development of alternative therapeutics. We present a protocol to evaluate the effectiveness of antimicrobial blue light (aBL) therapy for MDR Acinetobacter baumannii infections in mouse burns by using bioluminescence imaging.

Abstract

Burn infections continue to be an important cause of morbidity and mortality. The increasing emergence of multidrug-resistant (MDR) bacteria has led to the frequent failure of traditional antibiotic treatments. Alternative therapeutics are urgently needed to tackle MDR bacteria.

An innovative non-antibiotic approach, antimicrobial blue light (aBL), has shown promising effectiveness against MDR infections. The mechanism of action of aBL is not yet well understood. It is commonly hypothesized that naturally occurring endogenous photosensitizing chromophores in bacteria (e.g., iron-free porphyrins, flavins, etc.) are excited by aBL, which in turn produces cytotoxic reactive oxygen species (ROS) through a photochemical process.

Unlike another light-based antimicrobial approach, antimicrobial photodynamic therapy (aPDT), aBL therapy does not require the involvement of an exogenous photosensitizer. All it needs to take effect is the irradiation of blue light; therefore, it is simple and inexpensive. The aBL receptors are the endogenous cellular photosensitizers in bacteria, rather than the DNA. Thus, aBL is believed to be much less genotoxic to host cells than ultraviolet-C (UVC) irradiation, which directly causes DNA damage in host cells.

In this paper, we present a protocol to assess the effectiveness of aBL therapy for MDR Acinetobacter baumannii infections in a mouse model of burn injury. By using an engineered bioluminescent strain, we were able to noninvasively monitor the extent of infection in real time in living animals. This technique is also an effective tool for monitoring the spatial distribution of infections in animals.

Introduction

Burn infections, which are frequently reported because of cutaneous thermal injuries, continue to be an important cause of morbidity and mortality1. The management of burn infections has been further compromised by the increasing emergence of multidrug-resistant (MDR) bacterial strains2 due to the massive use of antibiotics. One important MDR Gram-negative bacteria is Acinetobacter baumannii, which is known to be associated with recent battle wounds and is resistant to almost all available antibiotics3. The presence of biofilms at the injured foci has been reported4

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Preparation of Bacterial Culture

  1. Add 7.5 mL of Brain Heart Infusion (BHI) medium to a 50 mL centrifuge tube. Seed A. baumannii cells in the BHI medium and then incubate the A. baumannii culture in an orbital incubator (37 °C) for 18 h.
  2. Centrifuge the culture of cells at 3,500 × g for 5 min, remove the supernatant, and wash the pellets in phosphate-buffered saline (PBS).
  3. Re-suspend the bacteria pellets in fresh PBS and thoroughly pipette the suspension.
  4. Collect 100 µL of the bacterial suspension and make a 1:10 dilution using fresh PBS.
  5. Transfer the dilution to a 1.5 mL semi-micro c....

Access restricted. Please log in or start a trial to view this content.

Results

The A. baumannii strain that we used is an MDR clinical isolate, as reported previously12,17. The bacterial strain was made bioluminescent by the transfection of luxCDABE opera11. Figure 1A shows the successive bacterial luminescence images from a representative mouse burn infected with 5 x 106A. baumannii and exposed to a single aBL exposure at 24 h af.......

Access restricted. Please log in or start a trial to view this content.

Discussion

aBL is a novel method for treating infections. Since its mechanism of action is completely different from that of chemotherapy, it is more of a physiotherapy. The agent that mediates the antimicrobial effect is blue light irradiation (400-470 nm). With the development of blue LEDs, we gained access to an effective and simple light-based antimicrobial approach for MDR infections.

In this protocol, we have described the development of a mouse model of burn infections caused by a bioluminescent s.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that they have no competing financial interests.

Acknowledgements

This work was supported in part by the Center for Integration of Medicine and Innovative Technology (CIMIT) under the U.S. Army Medical Research Acquisition Activity Cooperative Agreement (CIMIT No. 14-1894 to TD) and the National Institutes of Health (1R21AI109172 to TD). YW was supported by an ASLMS Student Research Grant (BS.S02.15). We are grateful to Tayyaba Hasan, PhD at the Wellman Center for her co-mentorship for YW.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
IVIS PerkinElmer Inc, Waltham, MAIVIS Lumina Series IIIPre-clinical in vivo imaging
Light-emitting diode LEDVieLight Inc, Toronto, Canada 415 nmLight source for illumination
Power/energy meterThorlabs, Inc., Newton, NJPM100DLight irradiance detector
Mouse Charles River Laboratories, Wilmington, MABALB/c7-8 weeks age, 17-19 g weight
Acinetobacter baumannii Brooke Army Medical Center, Fort Sam Houston, TXClinical isolateEngineered luminescent strain
Insulin SyringesFisher Scientific14-826-79BD Lo-Dose U-100 Insulin Syringes for injection
Sodium ChlorideFisher Scientific7210160.9% Sodium Chloride
Phosphate Buffered Saline, 1x SolutionFisher ScientificBP24384 A standard phosphate buffer used in many biomolecular procedures
Brain Heart InfusionFisher ScientificB11059Bacterial culture medium
Falcon 15 mL Conical Centrifuge TubesFisher Scientific14-959-70CFor bacterial suspension centrifuge
Benchtop Incubated Orbital ShakersLaboratory Supply Network, Inc, Atkinson, NH Incu-Shaker MiniFor culturing of bacteria
Inoculating LoopsFisher Scientific22-363-605  For smearing bacterial inoclum on burn surface of mice
Fisher Scientific Redi-Tip Pipet Tips, 1-200 µLFisher Scientific02-707-502Pipet Tips
Thermo Scientific Sorvall Legend X1 CentrifugeFisher Scientific75-004-220For bacterial suspension seperation
Brass BlockSmall Parts, Inc., Miami, FL10 mm by 10 mm For creation of burns in mice
Extreme Dragon PBI/Kevlar High-Heat GlovesSuperior Glove Works Ltd, Cheektowaga, NYPBI83514 Heat Resistant Gloves
Greiner dishesSigma-Aldrich Co. LLCP5112-740EA35 mm ×10 mm
Corning Digital Hot PlateCole-Parmer Instrument Company, LLCUX-84301-6510" x 10", 220 VAC, for boiling water 
Mouse/Rat Thin Line Water Heated Surgical BedE-Z SystemsEZ-211Prevents heat loss and hypothermia during surgery
Vet ointmentS&K Pharma, GmbHKerato Biciron 5%, Augensalbeopthalmic ointment to prevent eye dryness

References

  1. Gibran, N. S. Summary of the 2012 ABA Burn Quality Consensus conference. J Burn Care Res. 34 (4), 361-385 (2013).
  2. Sommer, R., Joachim, I., Wagner, S., Titz, A. New approaches to control infections: anti-biofilm strategies against gram-negative bacteria.....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Mouse ModelMultidrug-resistant BacteriaReactive Oxygen SpeciesPhotochemical ProcessHost Cell Safety